CHEMOTHERAPY
Vision of the IRPCM chemotherapy group:
-
Ascertain and reduce antimicrobial resistance levels in mollicutes to protect global human and animals for the future
-
-
Coordinating international agreed standards for MIC of mollicute species
-
mapping global resistance of mollicutes of human and veterinary importance
-
reducing unnecessary use of antimicrobials and promoting good stewardship
-
understanding the molecular mechanisms of resistance
-
evaluation of new and alternative agents
-
Current Goals:
-
To standardize veterinary mycoplasma antimicrobial sensitivity testing, including control strains and methodology like it was done for human mycoplasmas.
-
To continue work on molecular determinants of antimicrobial resistance:
-
Identifying breakpoints
-
Epidemiological surveillance
-
Monitoring of antimicrobial resistance
-
Development of the molecular assay to track antimicrobial resistance in the real-time
-
Molecular typing of strains with different susceptibility
-
Evaluation of new and alternative chemotherapeutic agents.

Team Leader